Philip Duey at the National Press Club, Washington DC, 1952

23749

Christiani Adolphi Thuldeni : Historia ab anno Christi M.DC.LII. in praesens usque tempus ; qua decem Germaniae in S.R. Imperio circuli, Octoviri Electores liique principes cum singulorum religionibus moenissimè describuntur ; ac res propè omnes in Francia, Suedia, Polonia, Anglia, caeterisque Europae totius regnis, cum cura & fide commemorantur ; [s]ubiecti sunt in annos singulos tractatus historico-politici, è quibus melior omnium propè bello & pace historiarum cognitio exsistit.

Prgt.

Fur pro tribunali. Examen dialogismi cui inscribitur fur praedestinatus. Accesserunt oratio de doctrina Neopelagiana habita Oxonii in Comitiis Julii IX. M. DC. LIV. Cl. V. G. Tuissii vita, et vindiciae à calumniis et sophismatis Francisci Annati Jesuita; et dissertatiuncula de novis actibus imminentibus sintne Deo ascribendi.

Mode of access: Internet.

Beitrage zur Embryologie von Ardisia crispa A.DC.

Thesis (doctoral)--Universitat Breslau.

Chemisch-pharmakognostische Untersuchung der Fruchte von Sapindus Rarak DC /

Thesis (doctoral)--Kaiser-Wilhelms-Universitat Strassburg, 1905.

Major facilities at the Naval Research Laboratory, Washington, DC 20375-5000.

Mode of access: Internet.

Central Valley Project Improvement Act : hearings before the Subcommittee on Water and Power of the Committee on Energy and Natural Resources, United States Senate, One Hundred Second Congress, first session, on S. 484 ... Los Angeles, CA, March 18, 1991; Washington, DC, May 6, 1991; Sacramento, CA, May 30, 1991.

"San Francisco, CA, September 4, 1991"--Pt. 2.

Hearings relating to Madison Guaranty S & L and the Whitewater Development Corporation, Washington, DC phase : hearings before the Committee on Banking, Housing, and Urban Affairs, United States Senate, One Hundred Third Congress, second session.

Shipping list no.: 95-0029-P (v. 1), 95-0027-P (v. 2), 95-0194-P (v. 3, 11), 95-0187-P (v. 4, 9, 14), 95-0177-P (v. 5, 8, 13, 17), 95-0205-P (v. 6), 95-0176-P (v. 10, 15-16, 18), 95-0121-P (v. 12), 95-0188-P (v. 19), 95-0185-P (v. 20-21, 23), 95-0199-P (v. 22), 95-0195-P (v. 24).

Effects of leukapheresis protocol, cell processing and cryopreservation on the generation of monocyte-derived DC for immune therapy

Background Many clinical trials of DC-based immunotherapy involve administration of monocyte-derived DCs (Mo-DC) on multiple occasions. We aimed to determine the optimal cell processing procedures and timing (leukapheresis, RBC depletion and cryopreservation) for generation of Mo-DC for clinical purposes. Methods Leukapheresis was undertaken using a COBE Spectra. Two instrument settings were compared - the standard semi-automated software (Version 4.7) (n = 10) and the fully automated software (Version 6.0) (n = 40). Density gradient centrifugation using Ficoll, Percoll, a combination of these methods or neither for RBC depletion were compared. Outcomes (including cell yield and purity) were compared for cryopreserved unmanipulated monocytes and cryopreserved Mo-DC. Results Software Version 6.0 provided significantly better enrichment for monocytes (P